Evidence map›Paper›PMID 35664473›Full record

ArticleFrontiers in psychiatry2022

Impact of COVID-19 Pandemic on Elevated Anxiety Symptoms of Maintenance Hemodialysis Patients in China: A One-Year Follow-Up Study.

Honghong Lv, Junping Meng, Yang Chen, Feng Yang, Wen Wang, Guohua Wei, Jiaojiao Zhang, Huan Wang, Mengqiu Wang, Lu Zhou and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Honghong LvDepartment of Nephrology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Junping MengDepartment of Nephrology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Yang ChenDepartment of Nephrology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Feng YangDepartment of Nephrology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Wen WangDepartment of Nephrology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Guohua WeiDepartment of Nephrology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Jiaojiao ZhangDepartment of Nephrology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Huan WangDepartment of Nephrology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Mengqiu WangDepartment of Nephrology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Lu ZhouDepartment of Nephrology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Hongbao LiuDepartment of Nephrology, Tangdu Hospital, The Air Force Military Medical University, Xi'an, China.
Tang Du Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have shown that coronavirus disease 2019 (COVID-19) aggravates anxiety in patients with maintenance hemodialysis (MHD), but it is still unclear how long this adverse effect will last. This study aims to investigate the impact of COVID-19 on the elevated anxiety symptoms of MHD patients 1 year after the outbreak. Assessment of elevated anxiety symptoms was performed on patients with MHD during early COVID-19 (February 17-February 29, 2020) and 1-year follow-up (March 1-March 13, 2021), and a total of 100 patients had completed face-to-face questionnaires at the first and 1-year follow-up. At the beginning of the outbreak, 40% of the patients with MHD had anxiety symptoms [self-rating anxiety scale (SAS) score ≥ 50], and 11% (SAS score: 60-69) and 2% (SAS score ≥ 70) of the patients had moderate and severe anxiety symptoms, respectively. Multivariate analysis shows that possibility of unaccompanied transfer, possibility of family members or themselves being infected in a hospital, added body temperature monitoring during dialysis, and increased medical procedures are the risk factors in elevated anxiety symptoms during early COVID-19. At the 1-year follow-up, the incidence of anxiety symptoms in the same group of patients declined to 28%, and all the patients had mild anxiety symptoms (SAS score: 50-59), which is significantly lower than that of the early COVID-19 pandemic with statistically significant difference (

Indexed as

anxietyCOVID-19dialysiskidneyrisk factors

Identifiers

PMID35664473
PMCPMC9160521
OpenAlexW4280603704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.